Treatment of Unstable Angina Pectoris/Non-ST-Segment Elevation Myocardial Infarction in Elderly Patients

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 58, Issue 10, 2003, Pages 927-933

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOCHEMICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; COLESTYRAMINE; CREATINE KINASE MB; DALTEPARIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FLUINDOSTATIN; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LONG ACTING DRUG; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; MORPHINE SULFATE; NITRATE; OXYGEN; PLACEBO; PRAVASTATIN; TIROFIBAN; TROPONIN I; TROPONIN T; UNINDEXED DRUG; VERAPAMIL;

AGING; ANGIOCARDIOGRAPHY; AORTA BALLOON; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; COUNTERPULSATION; DIABETES CONTROL; DIABETES MELLITUS; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG UTILIZATION; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY MONITORING; EXERCISE; GASTROINTESTINAL SYMPTOM; GERIATRIC CARE; HEART CATHETERIZATION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HORMONAL THERAPY; HOSPITALIZATION; HUMAN; OUTCOMES RESEARCH; OXYGEN THERAPY; POSTMENOPAUSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SCORING SYSTEM; SMOKING CESSATION; ST SEGMENT ELEVATION; SYMPTOM; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT PLANNING; UNSTABLE ANGINA PECTORIS; WEIGHT REDUCTION;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGINA, UNSTABLE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; ANTILIPEMIC AGENTS; ASPIRIN; CORONARY ANGIOGRAPHY; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; OXYGEN INHALATION THERAPY; TICLOPIDINE;

ANGINA;

EID: 0142094596     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Theroux P, Lidon R. Unstable angina: pathogenesis, diagnosis, and treatment. Curr Prob Cardiol. 1993;3:162-231.
2. Chesebro JH, Fuster V. Thrombosis in unstable angina. N Engl J Med. 1992;327:192-194.
3. Rizik D, Healy S, Margulis A, et al. A new clinical classification for hospital prognosis of unstable angina pectoris. Am J Cardiol. 1995;75: 993-997.
4. Woodworth S, Nayak D, Aronow WS, Pucillo AL, Koneru S. Comparison of acute coronary syndromes in men versus women ≥70 years of age. Am J Cardiol. 2002;90:1145-1147.
5. Nayak D, Woodworth S, Aronow WS, Pucillo AL, Koneru S. Acute coronary syndromes in elderly African-Americans versus elderly whites versus elderly patients of other races. Heart Dis. 2002;4:282-284.
6. Woodworth S, Nayak D, Aronow WS, Pucillo AL, Koneru S. Cardiovascular medications taken by patients aged ≥70 years hospitalized for acute coronary syndromes before hospitalization and at hospital discharge. Prev Cardiol. 2002;5:173-176.
7. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2000;36:970-1062.
8. Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation. 2000;101:2557-2567.
9. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835-842.
10. Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B Trial. Circulation, 1999;100:1593-1601.
11. Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med. 1997;337: 447-452.
12. Morrow DA, Antman EM, Snapinn SM, McCabe CH, Theroux P, Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST-elevation acute coronary syndromes: application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J. 2002;23:223-229.
13. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-1887.
14. Alpert JS, Thygesen K, Antman EM, Bassand JP. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
15. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40:1366-1374.
16. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
17. Mehta SR, Yusuf S, Peters RJG et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527-533.
18. O'Shea JC, Hafley GE, Greenberg S, et al. Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. JAMA. 2001;285:2468-2473.
19. Topol EJ, Moliterno DJ, Herrmann HC, et al. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med. 2001;344:1888-1894.
20. Roffi M, Moliterno DJ, Meier B, et al. Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up. Circulation. 2002;105:2730-2736.
21. Arntz HR, Agrawal R, Wunderlich W, et al. Beneficial effects of pravastatin (+/- cholestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). Am J Cardiol. 2000;86:1293-1298.
22. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL Study: a randomized controlled trial. JAMA. 2001;285:1711-1718.
23. Waters DD, Schwartz GG, Olsson AG, et al. Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction. A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Substudy. Circulation. 2002;106: 1690-1695.
24. Tonkin AM, Colquhoun D, Emberson J, et al. Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study. Lancet. 2000;355:1871-1875.
25. Aronow HD, Topol EJ, Roe MT, et al. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet. 2001;357:1063-1068.
26. Heeschen C, Hamm CW, Laufs U, Snapinn S, Bohn M, White HD, on behalf of the Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation. 2002;105:1446-1452.
27. Serruys PWJC, de Feyter P, Macaya C, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention. A randomized controlled trial. JAMA. 2002;287:3215-3222.
28. Aronow WS. Treatment of older persons with hypercholesterolemia with and without cardiovascular disease. J Gerontol Med Sci 2001;56A: M138-M145.
29. Aronow WS. Should hypercholesterolemia in older persons be treated to reduce cardiovascular events. J Gerontol Med Sci 2002;57A:M411-M413.
30. Antman EM, Cohen M, Radley D, et al. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction TIMI IIB-ESSENCE meta-analysis. Circulation. 1999;100: 1602-1608.
31. Goodman SG, Cohen M, Bigonzi F, et al. Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease. One-year results of the ESSENCE study. J Am Coll Cardiol. 2000;36:693-698.
32. Goodman SG, Barr A, Sobtchouk A, et al. Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST Segment Monitoring Substudy. J Am Coll Cardiol. 2000;36:1507-1513.
33. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial. Circulation. 1994;89:1545-1556.
34. Wallentin L, Lagerqvist B, Husted S, et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet. 2000; 356:9-16.
35. Aronow WS, Ahn C, Gutstein H. Prevalence and incidence of cardiovascular disease in 1,160 older men and 2,464 older women in a long-term health care facility. J Gerontol Med Sci. 2002;57A:M45-M46.
36. Aronow WS. What is the appropriate treatment of hypertension in elders? J Gerontol Med Sci. 2002;57A:M483-M486.
37. Kesani M, Aronow WS, Weiss B. Prevalence of multivessel coronary artery disease in patients with diabetes mellitus plus hypothyroidism, in patients with diabetes mellitus without hypothyroidism, and in patients with no diabetes mellitus or hypothyroidism. J Gerontol Med Sci. In press.